WallStSmart

Carlsmed, Inc. Common Stock (CARL)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 6349% more annual revenue ($2.89B vs $44.75M). MMED leads profitability with a -7.3% profit margin vs -57.5%. MMED earns a higher WallStSmart Score of 37/100 (F).

CARL

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 3.0Value: 5.0Quality: 5.0

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CARL2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
98.4%10/10

Revenue surging 98.4% year-over-year

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

MMED0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CARL4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$335.19M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-5.81M2/10

Negative free cash flow — burning cash

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CARL

The strongest argument for CARL centers on Revenue Growth, Price/Book. Revenue growth of 98.4% demonstrates continued momentum.

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : CARL

The primary concerns for CARL are EPS Growth, Market Cap, Return on Equity.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Key Dynamics to Monitor

CARL profiles as a hypergrowth stock while MMED is a turnaround play — different risk/reward profiles.

CARL is growing revenue faster at 98.4% — sustainability is the question.

CARL generates stronger free cash flow (-6M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMED scores higher overall (37/100 vs 31/100) and 13.1% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Carlsmed, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?